Patent US5087570A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5087570A Expired / Lapsed US ⏱️ 0.0 years remaining

Homogeneous mammalian hematopoietic stem cell composition

Assignee: Leland Stanford Junior University
•
Filing: 1988-05-10
•
Granted: 1992-02-11
•
Expires: 2008-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Highly concentrated hematopoietic stem cell compositions are provided which are substantially free of differentiated or dedicated hematopoietic cells. The cells are obtained by subtraction of cells having particular markers and selection of cells having particular markers. The resulting composition may be used to provide for individual or groups of hematopoietic lineages, to reconstitute stem cells of the host, and to identify an assay for a wide variety of hematopoietic growth factors.

Inventors

  • 👤 Irving L. Weissman
  • 👤 Gerald J. Spangrude
  • 👤 Christa Muller-Sieburg
  • 👤 Shelly Heimfeld

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 12:12
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/28; C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; Y; Y10; Y10S; Y10S436/00; Y10S436/807; Y10S436/808

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 23 words
A cell composition consisting essentially of as the cellular population viable murine hematopoietic Sca-1+ stem cells from a genetically identical or congenic source.
Claim 2
Dependent Claim 23 words
A cell composition consisting essentially of as the cellular population viable murine hematopoietic Sca-1+ stem cells from a genetically identical or congenic source.
Claim 3
Dependent Claim 16 words
A cell composition according to claim 1, wherein said cells are in a physiologically acceptable medium.
Claim 4
Dependent Claim 150 words
A method for preparing a cell composition according to claim 1, said method comprising: (1) separating a bone marrow cell population into a population characterized by T-cell markers, high levels of the thy-1 differentiation marker and markers of major cell populations of dedicated hematopoietic cells and a substantially T-cell free, low level thy-1 population also substantially free of markers of major cell populations of dedicated hematopoietic cells by means of T-cell markers, thy-1 differentiation markers and dedicated hematopoietic cell markers to provide a substantially T-cell free, low level thy-1 differentiation marker population also lacking markers characteristic of major cell populations of dedicated hematopoietic cells for use in the next step, (2) separating said bone marrow cell population of (1) into cells that bind to the Sca-1 antibody and those that do not bind, wherein said cells which bind to the Sca-1 antibody are a substantially homogeneous population of stem cells.
Claim 5
Dependent Claim 34 words
A method according to claim 3, wherein the separation into a T-cell marker positive and T-cell marker negative population is performed with magnetic beads and step (2) is performed by fluorescence activated cell sorting.
Claim 6
Dependent Claim 22 words
A method according to claim 3, wherein said cell composition is a mouse cell composition and said antibody is the Sca-1 antibody.
Claim 7
Dependent Claim 32 words
A method for enhancing the level of at least one hematopoietic cell type in a murine host, said method comprising: administering to said host a congenic cell composition according to claim 1.
Claim 8
Dependent Claim 27 words
A method for augmenting the immune response of an immunocomprised murine host, said method comprising: administering to said host a congenic cell composition according to claim 1.

References Cited (Backward Citations)

US4714680A Cited
US4714680B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-02-10 1995-08-12 1996-02-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-02-10 1999-08-12 2000-02-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-02-10 2003-08-12 2004-02-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag